Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases

Detalhes bibliográficos
Autor(a) principal: Festa Neto,Cyro
Data de Publicação: 2002
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962002000600006
Resumo: BACKGROUND: Topical treatment with 5% imiquimod cream has been demonstrated to be effective in patients with basal cell carcinoma. OBJECTIVES: In the present study, efficacy and tolerability of this treatment was analyzed in 10 patients with 13 different types of superficial and nodular basal cell carcinomas. METHODS: Imiquimod cream was applied daily for a mean period of 23 days. RESULTS AND CONCLUSIONS: All patients responded favorably to the drug with healing of the lesions. No recurrence was observed during two to three months of follow up.
id SBD-1_1955779c0036657c5a2714b32e7a8300
oai_identifier_str oai:scielo:S0365-05962002000600006
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 casesadjuvants, immunologiccarcinoma, basal cellBACKGROUND: Topical treatment with 5% imiquimod cream has been demonstrated to be effective in patients with basal cell carcinoma. OBJECTIVES: In the present study, efficacy and tolerability of this treatment was analyzed in 10 patients with 13 different types of superficial and nodular basal cell carcinomas. METHODS: Imiquimod cream was applied daily for a mean period of 23 days. RESULTS AND CONCLUSIONS: All patients responded favorably to the drug with healing of the lesions. No recurrence was observed during two to three months of follow up.Sociedade Brasileira de Dermatologia2002-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962002000600006Anais Brasileiros de Dermatologia v.77 n.6 2002reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/S0365-05962002000600006info:eu-repo/semantics/openAccessFesta Neto,Cyroeng2005-11-03T00:00:00Zoai:scielo:S0365-05962002000600006Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2005-11-03T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
title Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
spellingShingle Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
Festa Neto,Cyro
adjuvants, immunologic
carcinoma, basal cell
title_short Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
title_full Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
title_fullStr Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
title_full_unstemmed Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
title_sort Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases
author Festa Neto,Cyro
author_facet Festa Neto,Cyro
author_role author
dc.contributor.author.fl_str_mv Festa Neto,Cyro
dc.subject.por.fl_str_mv adjuvants, immunologic
carcinoma, basal cell
topic adjuvants, immunologic
carcinoma, basal cell
description BACKGROUND: Topical treatment with 5% imiquimod cream has been demonstrated to be effective in patients with basal cell carcinoma. OBJECTIVES: In the present study, efficacy and tolerability of this treatment was analyzed in 10 patients with 13 different types of superficial and nodular basal cell carcinomas. METHODS: Imiquimod cream was applied daily for a mean period of 23 days. RESULTS AND CONCLUSIONS: All patients responded favorably to the drug with healing of the lesions. No recurrence was observed during two to three months of follow up.
publishDate 2002
dc.date.none.fl_str_mv 2002-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962002000600006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962002000600006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0365-05962002000600006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.77 n.6 2002
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126414013857792

Registros relacionados